✦ LIBER ✦

C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial

✍ Scribed by M. P. Bjorkman; A. J. Sorva; R. S. Tilvis

Book ID: 107669848
Publisher: Springer
Year: 2009
Tongue: English
Weight: 104 KB
Volume: 13
Category: Article
ISSN: 1279-7707
DOI: 10.1007/s12603-009-0080-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of six months of vitamin D suppl

Effects of six months of vitamin D supplementation in patients with heart failure: A randomized double-blind controlled trial

✍ Dalbeni, A.; Scaturro, G.; Degan, M.; Minuz, P.; Delva, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 530 KB

Serum levels of vitamin D and C reactive

Serum levels of vitamin D and C reactive protein in patients with hyperemesis gravidarum

✍ Yilmaz, S.; Timur, H.; Yaman, S.; Sahin, A.; Aktulay, A.; Danisman, N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The Effects of Vitamin D Supplementation

The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Patients With Heart Failure: A Randomized Controlled Trial

✍ Witham, M. D.; Crighton, L. J.; Gillespie, N. D.; Struthers, A. D.; McMurdo, M. 📂 Article 📅 2010 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 364 KB

OP-035 EFFECTS OF CARVEDIOLOL ON HIGH SE

OP-035 EFFECTS OF CARVEDIOLOL ON HIGH SENSITIVITY C-REACTIVE PROTEIN AND FIBRINOGEN IN PATIENTS WITH HEART FAILURE

✍ A. Dogan; M. Karabacak; M. Ozaydin; E. Varol; D. Erdogan; H. Yucel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The effects of rosiglitazone, a peroxiso

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

✍ J.S. Sidhu; D. Cowan; J.C. Kaski 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Effects of aspirin on serum C-reactive p

Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial

✍ M. M. C. Hovens; J. D. Snoep; Y. Groeneveld; M. Frölich; J. T. Tamsma; M. V. Hui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB